ORCHESTRA BIOMED HOLDINGS INC. - ORDINARY SHARES

Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon

29 апр 2025 09:00:00 Источник Nasdaq GlobeNewswire

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences

28 апр 2025 16:30:00 Источник Nasdaq GlobeNewswire

Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting

23 апр 2025 09:00:13 Источник Nasdaq GlobeNewswire

Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy

22 апр 2025 07:00:00 Источник Nasdaq GlobeNewswire

Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update

31 мар 2025 16:21:30 Источник Nasdaq GlobeNewswire

Orchestra BioMed to Present at Upcoming Investor Conferences

20 фев 2025 08:00:00 Источник Nasdaq GlobeNewswire

Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board

18 фев 2025 08:00:01 Источник Nasdaq GlobeNewswire

Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference

12 фев 2025 10:43:00 Источник Nasdaq GlobeNewswire

Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors

05 фев 2025 08:00:00 Источник Nasdaq GlobeNewswire

Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting

09 дек 2024 07:00:00 Источник Nasdaq GlobeNewswire

Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference

26 ноя 2024 16:05:00 Источник Nasdaq GlobeNewswire

Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update

12 ноя 2024 16:12:39 Источник Nasdaq GlobeNewswire

Orchestra BioMed to Participate in Jefferies London Healthcare Conference

07 ноя 2024 08:00:01 Источник Nasdaq GlobeNewswire

Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update

12 авг 2024 16:20:20 Источник Nasdaq GlobeNewswire

Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors

30 июл 2024 08:00:00 Источник Nasdaq GlobeNewswire

Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024

04 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire

Orchestra BioMed to Participate in Jefferies Global Healthcare Conference

22 май 2024 08:43:18 Источник Nasdaq GlobeNewswire

Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update

13 май 2024 16:58:13 Источник Nasdaq GlobeNewswire

Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents

30 апр 2024 08:30:00 Источник Nasdaq GlobeNewswire

Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024

30 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire